Related references
Note: Only part of the references are listed.Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
David Simon et al.
ARTHRITIS & RHEUMATOLOGY (2022)
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Satveer K. Mahil et al.
LANCET RHEUMATOLOGY (2021)
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
Jerome Avouac et al.
LANCET RHEUMATOLOGY (2021)
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Florence Aeschlimann et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
David Simon et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS-CoV-2 vaccination in patients with rheumatic diseases
Robert Spiera et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
Filippo Massa et al.
EBIOMEDICINE (2021)
IMPACT OF ABDOMINAL AORTIC CALCIFICATION AND SERUM CREATININE-TO-CYSTATIN C RATIO TO BONE FRAGILITY FRACTURE
I. Yoshii
ANNALS OF THE RHEUMATIC DISEASES (2021)
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
Yolanda Braun-Moscovici et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Daniel Mrak et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
Serena Bugatti et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Lee M. Greenberger et al.
CANCER CELL (2021)
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
Ilies Benotmane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner et al.
NATURE (2021)
How the Delta variant achieves its ultrafast spread
Sara Reardon
NATURE (2021)
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Ugur Sahin et al.
NATURE (2021)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
Jin Kyun Park et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Charlotte Hua et al.
ARTHRITIS CARE & RESEARCH (2014)
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response
S. Oren et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)